Patheon Inc. is a provider of commercial manufacturing outsourcing services (CMO) and outsourced pharmaceutical development services (PDS) to the global pharmaceutical industry. The Company offers a range of services throughout the lifecycle of a pharmaceutical molecule, from early development, through late development to commercial manufacturing, including lifecycle management services. The Company operates in two segments: CMO and PDS. The Company’s CMO business focuses on prescription products in a range of solid and sterile dosage forms. Its PDS business provides a range of development services, including finished dosage formulation across approximately 40 dosage forms, early development services, analytical services, formulation expertise and life cycle management. On March 11, 2014, JLL/Delta Canada Inc., an indirect subsidiary of JLL/Delta Patheon Holdings, L.P., and the Company were amalgamated.